TuisMEHCQ • OTCMKTS
add
Chrome Holding Co
Vorige sluiting
$3,16
Dagwisseling
$3,13 - $3,20
Jaarwisseling
$0,47 - $6,21
Markkapitalisasie
88,13 m USD
Gemiddelde volume
50,03 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
OTCMKTS
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Jun. 2025info | J/J-verandering |
---|---|---|
Inkomste | 25,42 m | -37,10% |
Bedryfskoste | 44,24 m | -43,21% |
Netto inkomste | -23,83 m | 65,67% |
Netto winsgrens | -93,74 | 45,41% |
Wins per aandeel | — | — |
EBITDA | -28,49 m | 46,78% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Jun. 2025info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 39,83 m | -76,57% |
Totale bates | 144,33 m | -60,79% |
Totale aanspreeklikheid | 187,19 m | -16,64% |
Totale ekwiteit | -42,86 m | — |
Uitstaande aandele | 27,54 m | — |
Prys om te bespreek | -2,03 | — |
Opbrengs op bates | -50,47% | — |
Opbrengs op kapitaal | 438,85% | — |
Kontantvloei
Netto kontantverandering
(USD) | Jun. 2025info | J/J-verandering |
---|---|---|
Netto inkomste | -23,83 m | 65,67% |
Kontant van bedrywe | -28,99 m | 33,00% |
Kontant van beleggings | -1,03 m | 10,64% |
Kontant van finansiering | 24,28 m | 269 711,11% |
Netto kontantverandering | -5,74 m | 87,07% |
Beskikbare kontantvloei | 22,86 m | 281,90% |
Meer oor
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously confrontational relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Gestig
Apr. 2006
Webwerf
Werknemers
261